Financial burden and quality of life among early‐onset colorectal cancer survivors: A qualitative analysis

Blum‐Barnett, Erica; Madrid, Sarah; Burnett‐Hartman, Andrea N.; Mueller, Shane R.; McMullen, Carmit K.; Dwyer, Andrea; Feigelson, Heather Spencer

doi:10.1111/hex.12919

Cited by 43 publications

(100 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We reduced the number of papers to 98 by reading the titles and abstracts. Subsequently, an additional 84 studies were excluded after reading the full texts, and 14 studies remained …”

Section: Resultsmentioning

confidence: 99%

“…One study reported that the researchers' role may impact the interpretation of the findings . Three studies failed to provide sufficient details about the ethical approval process …”

Section: Resultsmentioning

confidence: 99%

“…Nine studies used individual in‐depth or semistructured interviews to collect data. Other data collection methods included flexible interviews, open‐ended questionnaires, focus group interviews, and nominal group technique methods . Seven studies recruited participants from multiple sites .…”

Section: Resultsmentioning

confidence: 99%

“…This synthesized finding was derived from seven findings and was grouped into two categories: information needs and practical needs. Cancer patients lack information about treatment costs, cancer's potential effect on their finances, insurance coverage, and supportive agencies or programs . Unmet practical needs included affordable insurance, social resources (social workers, navigators, support groups), and upfront money …”

Section: Resultsmentioning

confidence: 99%

“…The meta‐synthesis revealed that cancer‐related FT extends beyond medical issues and varies by the phase of survivorship. Even if cancer survivors have no signs of cancer after initial treatment, FT will be further increased due to the impact of cancer on work performance and income and difficulty in returning to work and with family support . Previous studies noted that psychological and social distress caused by cancer are easily undetected by healthcare professionals and may result in more than 22.3 missed workdays per year and reductions in income .…”

Section: Discussionmentioning

confidence: 99%

See 4 more Smart Citations

Cancer survivors' experiences with financial toxicity: A systematic review and meta‐synthesis of qualitative studies

Zhu

Xing

et al. 2020

Psycho-Oncology

View full text Add to dashboard Cite

Objective The aim of this study was to synthesize qualitative research evidence on cancer survivors' experiences with financial toxicity (FT). Methods We carried out a systematic review of qualitative studies using a meta‐aggregation approach. Papers published prior to 31 August 2019, were collected from electronic databases, including PubMed/MEDLINE, MEDLINE (Ovid), EMBASE (Ovid), CINAHL (EBSCO), Web of Science, ProQuest Dissertations and Theses, and Cochrane Library (Wiley). Results Six synthesized findings were derived from 14 studies covering cancer patients' awareness of FT, cancer‐related expenditures, and the risk factors, impacts, coping strategies, and unmet needs related to FT. Conclusions Cancer survivors incur FT; however, their awareness of FT is limited. Cancer‐related FT has multiple impacts on survivors' lives. Although cancer survivors try to cope with FT through adjustments, they still have unmet needs for the management of FT. Nurses and social workers can play a critical role in helping survivors manage FT by increasing pre‐awareness of FT, strengthening emotional empowerment, and providing personalized informative support.

show abstract

“…We reduced the number of papers to 98 by reading the titles and abstracts. Subsequently, an additional 84 studies were excluded after reading the full texts, and 14 studies remained …”

Section: Resultsmentioning

confidence: 99%

“…One study reported that the researchers' role may impact the interpretation of the findings . Three studies failed to provide sufficient details about the ethical approval process …”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Cancer survivors' experiences with financial toxicity: A systematic review and meta‐synthesis of qualitative studies

Zhu

Xing

et al. 2020

Psycho-Oncology

View full text Add to dashboard Cite

show abstract

Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019

Koh

Tan

et al. 2023

JAMA Netw Open

View full text Add to dashboard Cite

ImportanceEmerging data suggest that the incidence of early-onset cancers, defined as cancers diagnosed in people younger than 50 years, is increasing, but updated data are limited.ObjectiveTo characterize the patterns in the incidence of early-onset cancers in the US from 2010 to 2019 and provide granular data on the cancers with the fastest-growing incidence rates.Design, Setting, and ParticipantsThis population-based cohort study analyzed data from 17 National Cancer Institute Surveillance, Epidemiology, and End Results registries from January 1, 2010, to December 31, 2019. Age-standardized incidence rates per 100 000 people were extracted for early-onset cancers, with rates age adjusted to the US standard population. A total of 562 145 patients with early-onset cancer between 2010 and 2019 were identified and included. Data were analyzed from October 16, 2022, to May 23, 2023.Main Outcomes and MeasuresPrimary outcomes were incidence rates and descriptive epidemiological data for people younger than 50 years with cancer. The annual percentage change (APC) of the age-standardized incidence rate was estimated using the Joinpoint regression program.ResultsAmong 562 145 patients (324 138 [57.7%] aged 40-49 years; 351 120 [62.5%] female) with early-onset cancer, 4565 (0.8%) were American Indian or Alaska Native, 54 876 (9.8%) were Asian or Pacific Islander, 61 048 (10.9%) were Black, 118 099 (21.0%) were Hispanic, 314 610 (56.0%) were White, and 8947 (1.6%) were of unknown race and/or ethnicity. From 2010 to 2019, the age-standardized incidence rate of early-onset cancers increased overall (APC, 0.28%; 95% CI, 0.09%-0.47%; P = .01) and in female individuals (APC, 0.67%; 95% CI, 0.39%-0.94%; P = .001) but decreased in male individuals (APC, −0.37%; 95% CI, −0.51% to −0.22%; P &lt; .001). In contrast, the age-standardized incidence rate of cancers in individuals aged 50 years and older decreased over the study period (APC, −0.87%; 95% CI, −1.06% to −0.67%; P &lt; .001). In 2019, the highest number of incident cases of early-onset cancer were in the breast (n = 12 649). From 2010 to 2019, gastrointestinal cancers had the fastest-growing incidence rates among all early-onset cancer groups (APC, 2.16%; 95% CI, 1.66%-2.67%; P &lt; .001). Among gastrointestinal cancers, those with the fastest-growing incidence rates were in the appendix (APC, 15.61%; 95% CI, 9.21%-22.38%; P &lt; .001), intrahepatic bile duct (APC, 8.12%; 95% CI, 4.94%-11.39%; P &lt; .001), and pancreas (APC, 2.53%; 95% CI, 1.69%-3.38%; P &lt; .001).Conclusions and RelevanceIn this cohort study, the incidence rates of early-onset cancer increased from 2010 to 2019. Although breast cancer had the highest number of incident cases, gastrointestinal cancers had the fastest-growing incidence rates among all early-onset cancers. These data may be useful for the development of surveillance strategies and funding priorities.

show abstract

Understanding the psychosocial impact of colorectal cancer on young‐onset patients: A scoping review

et al. 2022

View full text Add to dashboard Cite

Objective:The incidence of young-onset (<50 years) colorectal cancer (CRC) has been increasing internationally. The psychosocial experience of younger cancer patients is vastly different from older patients, especially in domains such as financial toxicity, body image, and sexual dysfunction. What is unknown is the cancer type-specific experience. The aim of the current scoping review was to examine (1) the psychosocial factors and/or outcomes associated with young-onset CRC and (2) other determinants that influences these outcomes. Methods:A systematic search was conducted on four databases (PubMed, CINAHL, Scopus and PsycINFO) from inception to December 2020 using key terms and combinations. Primary literature that examined the psychosocial (e.g., quality-of-life, emotional, social, sexual) impact of young-onset CRC were included.Results: A total of 1389 records were assessed by four reviewers, with a total of seven studies meeting inclusion criteria (n = 5 quantitative, n = 1 qualitative and n = 1 case series). All studies indicated there was significant psychosocial impact in younger CRC patients, including emotional impact, social impact, physical burden, sexual impact, work impact, unmet needs, financial impact and global quality of life. Three studies explored other determinants that influenced the psychosocial experience and found that socioeconomic background (e.g., being female, lower education), CRC treatment (e.g., chemotherapy) and health status were associated with worse psychosocial impact.Conclusions: Young-onset CRC patients face severe psychosocial impact unique to this age group, such as self-image and sexual impact. Social support services and resources needs to be uniquely tailored. More empirical investigations are required to understand its long-term impact and influence of other psychosocial domains.

show abstract

Financial burden and quality of life among early‐onset colorectal cancer survivors: A qualitative analysis

Cited by 43 publications

References 30 publications

Cancer survivors' experiences with financial toxicity: A systematic review and meta‐synthesis of qualitative studies

Cancer survivors' experiences with financial toxicity: A systematic review and meta‐synthesis of qualitative studies

Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019

Understanding the psychosocial impact of colorectal cancer on young‐onset patients: A scoping review

Contact Info

Product

Resources

About